Published in J Natl Cancer Inst on September 15, 1999
Women Informed to Screen Depending on Measures of Risk (WISDOM) | NCT02620852
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer. Cancer Prev Res (Phila) (2010) 5.81
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst (2008) 4.52
Atypical hyperplasia of the breast--risk assessment and management options. N Engl J Med (2015) 3.57
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med (2014) 3.09
Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model. J Natl Cancer Inst (2009) 3.04
Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res (2007) 2.71
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35
Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol (2015) 2.25
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet (2003) 2.24
Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med (2014) 2.08
Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol (2008) 2.06
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. J Clin Oncol (2011) 2.00
Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst (2011) 1.94
Technological innovation and inequality in health. Demography (2008) 1.87
Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative. Cancer (2008) 1.84
Translational research in cancer genetics: the road less traveled. Public Health Genomics (2009) 1.65
Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials. Cancer Prev Res (Phila) (2012) 1.63
Validation of biomarker-based risk prediction models. Clin Cancer Res (2008) 1.57
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk. J Natl Cancer Inst (2008) 1.56
Risk-benefit profiles of women using tamoxifen for chemoprevention. J Natl Cancer Inst (2014) 1.51
Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst (2010) 1.51
Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst (2011) 1.51
Personalized estimates of breast cancer risk in clinical practice and public health. Stat Med (2011) 1.49
Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR). Am J Obstet Gynecol (2011) 1.48
Validation of a breast cancer risk prediction model developed for Black women. J Natl Cancer Inst (2013) 1.46
A novel automated mammographic density measure and breast cancer risk. J Natl Cancer Inst (2012) 1.28
Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump. Ann Fam Med (2005) 1.28
A framework for evaluating markers used to select patient treatment. Med Decis Making (2013) 1.25
Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance. Breast Cancer Res (2012) 1.24
Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol (2009) 1.23
A clinical risk prediction model for Barrett esophagus. Cancer Prev Res (Phila) (2012) 1.21
Predictors of pessimistic breast cancer risk perceptions in a primary care population. J Gen Intern Med (2004) 1.20
Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial. Cancer Prev Res (Phila) (2011) 1.19
Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer (2009) 1.16
Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers. J Clin Oncol (2012) 1.15
Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study. Breast Cancer Res (2008) 1.12
Risk determination and prevention of breast cancer. Breast Cancer Res (2014) 1.11
Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. PLoS Med (2013) 1.11
Breast cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. J S C Med Assoc (2006) 1.10
Breast cancer risk-assessment models. Breast Cancer Res (2007) 1.09
Breast cancer risk and provider recommendation for mammography among recently unscreened women in the United States. J Gen Intern Med (2006) 1.06
Effect of changing breast cancer incidence rates on the calibration of the Gail model. J Clin Oncol (2010) 1.05
Combining information from multiple data sources to create multivariable risk models: illustration and preliminary assessment of a new method. J Biomed Biotechnol (2005) 1.05
Can the breast screening appointment be used to provide risk assessment and prevention advice? Breast Cancer Res (2015) 1.01
Longitudinal association of anthropometry with mammographic breast density in the Study of Women's Health Across the Nation. Int J Cancer (2009) 1.00
Evaluating breast cancer risk projections for Hispanic women. Breast Cancer Res Treat (2011) 0.99
Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion. Cancer (2010) 0.99
Korean risk assessment model for breast cancer risk prediction. PLoS One (2013) 0.98
The relation between projected breast cancer risk, perceived cancer risk, and mammography use. Results from the National Health Interview Survey. J Gen Intern Med (2005) 0.98
Recruiting research participants at community education sites. J Cancer Educ (2005) 0.98
Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis. Br J Cancer (2011) 0.97
Applying the Lorenz curve to disease risk to optimize health benefits under cost constraints. Stat Interface (2009) 0.97
Breast cancer risk assessments comparing Gail and CARE models in African-American women. Breast J (2009) 0.95
Common breast cancer risk variants in the post-COGS era: a comprehensive review. Breast Cancer Res (2013) 0.94
Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev (2015) 0.92
Solid tumor second primary neoplasms: who is at risk, what can we do? Semin Oncol (2013) 0.92
Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer. Fam Cancer (2012) 0.92
Exogenous and endogenous hormones and breast cancer. Best Pract Res Clin Endocrinol Metab (2008) 0.91
Acceptance and adherence to chemoprevention among women at increased risk of breast cancer. Breast (2014) 0.90
Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women. Breast Cancer Res (2012) 0.90
Estrogen metabolism and breast cancer. Cancer Lett (2014) 0.89
Making sense of cancer risk calculators on the web. J Gen Intern Med (2008) 0.89
Missed opportunities: family history and behavioral risk factors in breast cancer risk assessment among a multiethnic group of women. J Gen Intern Med (2007) 0.89
The use of tamoxifen and raloxifene for the prevention of breast cancer. Recent Results Cancer Res (2009) 0.89
Breast MRI use uncommon among U.S. women. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Five-year and lifetime risk of breast cancer among U.S. subpopulations: implications for magnetic resonance imaging screening. Cancer Epidemiol Biomarkers Prev (2010) 0.88
Prevalence and correlates of recent and repeat mammography among California women ages 55-79. Cancer Epidemiol (2010) 0.88
Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer. J Clin Oncol (2014) 0.88
Differences in reproductive risk factors for breast cancer in middle-aged women in Marin County, California and a sociodemographically similar area of Northern California. BMC Womens Health (2009) 0.87
Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials. Breast Cancer Res Treat (2011) 0.87
Two-stage sampling designs for external validation of personal risk models. Stat Methods Med Res (2013) 0.87
Breast ductal lavage for assessment of breast cancer biomarkers. Horm Cancer (2010) 0.87
Application of the Rosner-Colditz risk prediction model to estimate sexual orientation group disparities in breast cancer risk in a U.S. cohort of premenopausal women. Cancer Epidemiol Biomarkers Prev (2012) 0.87
Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women. Breast Cancer Res Treat (2010) 0.86
A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women. Br J Cancer (2015) 0.86
Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model. Breast Cancer Res Treat (2013) 0.85
Barriers and Facilitators to Patient-Provider Communication When Discussing Breast Cancer Risk to Aid in the Development of Decision Support Tools. AMIA Annu Symp Proc (2015) 0.85
Risk factors for breast cancer in postmenopausal Caucasian and Chinese-Canadian women. Breast Cancer Res (2010) 0.84
Correlation of ductal lavage cytology with ductoscopy-directed duct excision histology in women at high risk for developing breast cancer: a prospective, single-institution trial. Ann Surg Oncol (2011) 0.84
Tamoxifen chemoprevention treatment and time to first diagnosis of estrogen receptor-negative breast cancer. J Natl Cancer Inst (2008) 0.83
Chemoprevention for Breast Cancer. Ann Surg Oncol (2015) 0.83
Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer. Patient Educ Couns (2013) 0.83
The risk of developing invasive breast cancer in Hispanic women : a look across Hispanic subgroups. Cancer (2012) 0.82
Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial. Cancer (2011) 0.82
Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention. Curr Breast Cancer Rep (2012) 0.82
A randomized trial of three videos that differ in the framing of information about mammography in women 40 to 49 years old. J Gen Intern Med (2003) 0.82
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Breast Cancer Res (2015) 0.81
Breast cancer risk prediction and mammography biopsy decisions: a model-based study. Am J Prev Med (2013) 0.81
Vascular endothelial growth factor and breast cancer risk. Cancer Causes Control (2008) 0.81
Prospective screening study of 0.5 Tesla dedicated magnetic resonance imaging for the detection of breast cancer in young, high-risk women. BMC Womens Health (2006) 0.80
Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study. Breast Cancer Res Treat (2013) 0.80
Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women. Breast Cancer (Dove Med Press) (2011) 0.80
Why Breast Cancer Risk by the Numbers Is Not Enough: Evaluation of a Decision Aid in Multi-Ethnic, Low-Numerate Women. J Med Internet Res (2015) 0.80
First do no harm: extending the debate on the provision of preventive tamoxifen. Br J Cancer (2001) 0.80
Breast cancer risk feedback to women in the UK NHS breast screening population. Br J Cancer (2016) 0.79
Impact of preventive therapy on the risk of breast cancer among women with benign breast disease. Breast (2015) 0.79
Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR). Cancer Prev Res (Phila) (2012) 0.79
The construct of breast cancer risk perception: need for a better risk communication? Facts Views Vis Obgyn (2009) 0.78
Sequence and organization of the human mitochondrial genome. Nature (1981) 57.39
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst (1998) 22.10
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med (1996) 11.76
Complete sequence of bovine mitochondrial DNA. Conserved features of the mammalian mitochondrial genome. J Mol Biol (1982) 11.71
Shotgun DNA sequencing using cloned DNase I-generated fragments. Nucleic Acids Res (1981) 8.23
Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med (1991) 7.21
Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet (2000) 7.16
Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst (1994) 6.37
Randomized clinical trials. Perspectives on some recent ideas. N Engl J Med (1976) 5.86
Determinants and consequences of smoke-free homes: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 5.63
Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med (1995) 5.45
Spectrum of AIDS-associated malignant disorders. Lancet (1998) 5.30
Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med (1995) 5.27
A short primer for sequencing DNA cloned in the single-stranded phage vector M13mp2. Nucleic Acids Res (1980) 4.98
Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA (1994) 4.35
Distinctive sequence of human mitochondrial ribosomal RNA genes. Nature (1980) 4.30
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol (1989) 4.03
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer (1983) 3.94
Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA (1993) 3.91
Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens (1988) 3.86
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med (1989) 3.83
Different pattern of codon recognition by mammalian mitochondrial tRNAs. Proc Natl Acad Sci U S A (1980) 3.74
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol (1989) 3.44
Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol (2005) 3.34
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med (1994) 3.29
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst (2000) 3.27
Biased selection of controls for case-control analyses of cohort studies. Biometrics (1984) 3.25
Complete mitochondrial genome sequences of two extinct moas clarify ratite evolution. Nature (2001) 3.12
Prescribing at the hospital-general practice interface. I: Hospital outpatient dispensing policies in England. BMJ (1992) 3.09
Effects of the 2003 advertising/promotion ban in the United Kingdom on awareness of tobacco marketing: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 3.05
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol (1997) 3.04
Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst (1995) 3.03
Counselling in general practice. J R Coll Gen Pract (1979) 2.99
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest (1985) 2.99
Implication of a novel multiprotein Dam1p complex in outer kinetochore function. J Cell Biol (2001) 2.98
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest (1986) 2.96
A mutant of Arabidopsis deficient in the chloroplast 16:1/18:1 desaturase. Plant Physiol (1989) 2.93
Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex Transm Infect (2004) 2.92
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest (1986) 2.91
Genetic Bit Analysis: a solid phase method for typing single nucleotide polymorphisms. Nucleic Acids Res (1994) 2.79
The locomotion of mouse fibroblasts in tissue culture. Biophys J (1970) 2.75
Fruit and vegetables in the American diet: data from the NHANES II survey. Am J Public Health (1990) 2.75
Involvement of DNA polymerase alpha in simian virus 40 DNA replication. J Biol Chem (1978) 2.74
Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann Intern Med (1995) 2.74
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet (1991) 2.70
Impaired development of Th2 cells in IL-13-deficient mice. Immunity (1998) 2.68
Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med (1988) 2.61
Attributable risk estimation in case-control studies. Epidemiol Rev (1994) 2.60
Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci U S A (1991) 2.55
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol (1998) 2.51
An analysis of comparative carcinogenesis experiments based on multiple times to tumor. Biometrics (1980) 2.45
Attributable risk: advantages of a broad definition of exposure. Am J Epidemiol (1994) 2.45
Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet (1999) 2.42
Estimates of absolute cause-specific risk in cohort studies. Biometrics (1990) 2.42
Should we adjust for covariates in nonlinear regression analyses of randomized trials? Control Clin Trials (1998) 2.40
High-level production of uniformly ¹⁵N- and ¹³C-enriched fusion proteins in Escherichia coli. J Biomol NMR (1996) 2.38
Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst (1995) 2.36
Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet (1986) 2.28
On design considerations and randomization-based inference for community intervention trials. Stat Med (1996) 2.25
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med (1997) 2.25
Internal jugular vein thrombosis: outcome and risk factors. QJM (2010) 2.24
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med (1987) 2.24
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med (2015) 2.18
Fraud in breast-cancer trials. N Engl J Med (1994) 2.18
Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice. Blood (2000) 2.16
Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology (1999) 2.16
Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet (1992) 2.15
Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst (2001) 2.12
Long-term mortality study of steelworkers. VI. Mortality from malignant neoplasms among coke oven workers. J Occup Med (1972) 2.11
Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer (1994) 2.09
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop. Control Clin Trials (2001) 2.06
Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. J Chronic Dis (1981) 2.03
The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia. Nat Genet (1999) 2.02
Effect of colcemid on fibroblast motility. Exp Cell Res (1971) 2.01
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology (2010) 2.01
Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science (1988) 1.97
Isolation of a genomic clone for bovine pancreatic trypsin inhibitor by using a unique-sequence synthetic DNA probe. Proc Natl Acad Sci U S A (1983) 1.96
Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol (1991) 1.93
Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol (1994) 1.93
Cancer experience among coke by-product workers. Ann N Y Acad Sci (1976) 1.93
Cell migration from the ganglionic eminences is required for the development of hippocampal GABAergic interneurons. Neuron (2000) 1.91
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol (2001) 1.87
Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res (1989) 1.86
Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J Virol (1989) 1.86
Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project. World J Surg (1994) 1.86
Variance calculations and confidence intervals for estimates of the attributable risk based on logistic models. Biometrics (1990) 1.83
Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry (2001) 1.81
Liver regeneration in dogs: morphologic and chemical changes. J Surg Res (1978) 1.78
Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med (1994) 1.77
Wound recurrence following conventional treatment of colorectal cancer. A rare but perhaps underestimated problem. Dis Colon Rectum (1996) 1.77
Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res (1994) 1.77
An olfactory sensory map develops in the absence of normal projection neurons or GABAergic interneurons. Neuron (1998) 1.76
More on "Biased selection of controls for case-control analyses of cohort studies". Biometrics (1986) 1.76